Globus Medical ROA 2012-2026 | GMED
Current and historical return on assets (ROA) values for Globus Medical (GMED) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Globus Medical ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $0.59B | $5.20B | 11.29% |
| 2025-12-31 | $0.54B | $5.02B | 10.72% |
| 2025-09-30 | $0.42B | $5.01B | 8.47% |
| 2025-06-30 | $0.36B | $5.00B | 7.14% |
| 2025-03-31 | $0.19B | $5.01B | 3.71% |
| 2024-12-31 | $0.10B | $5.07B | 2.05% |
| 2024-09-30 | $0.09B | $5.03B | 1.83% |
| 2024-06-30 | $0.04B | $5.10B | 0.80% |
| 2024-03-31 | $0.07B | $4.40B | 1.52% |
| 2023-12-31 | $0.12B | $3.70B | 3.32% |
| 2023-09-30 | $0.16B | $2.95B | 5.36% |
| 2023-06-30 | $0.20B | $2.10B | 9.70% |
| 2023-03-31 | $0.20B | $2.03B | 9.90% |
| 2022-12-31 | $0.19B | $1.99B | 9.54% |
| 2022-09-30 | $0.16B | $1.96B | 7.90% |
| 2022-06-30 | $0.16B | $1.95B | 7.97% |
| 2022-03-31 | $0.14B | $1.92B | 7.38% |
| 2021-12-31 | $0.15B | $1.86B | 8.02% |
| 2021-09-30 | $0.19B | $1.79B | 10.45% |
| 2021-06-30 | $0.18B | $1.70B | 10.84% |
| 2021-03-31 | $0.12B | $1.61B | 7.53% |
| 2020-12-31 | $0.10B | $1.54B | 6.62% |
| 2020-09-30 | $0.10B | $1.51B | 6.31% |
| 2020-06-30 | $0.09B | $1.48B | 6.00% |
| 2020-03-31 | $0.15B | $1.46B | 10.11% |
| 2019-12-31 | $0.16B | $1.43B | 10.86% |
| 2019-09-30 | $0.15B | $1.37B | 10.66% |
| 2019-06-30 | $0.14B | $1.32B | 10.86% |
| 2019-03-31 | $0.15B | $1.27B | 11.83% |
| 2018-12-31 | $0.16B | $1.22B | 12.92% |
| 2018-09-30 | $0.14B | $1.16B | 12.41% |
| 2018-06-30 | $0.14B | $1.11B | 12.17% |
| 2018-03-31 | $0.12B | $1.06B | 11.23% |
| 2017-12-31 | $0.11B | $1.02B | 10.61% |
| 2017-09-30 | $0.11B | $0.98B | 11.02% |
| 2017-06-30 | $0.11B | $0.95B | 11.41% |
| 2017-03-31 | $0.11B | $0.92B | 11.48% |
| 2016-12-31 | $0.10B | $0.89B | 11.75% |
| 2016-09-30 | $0.12B | $0.86B | 13.70% |
| 2016-06-30 | $0.12B | $0.84B | 14.11% |
| 2016-03-31 | $0.12B | $0.81B | 14.32% |
| 2015-12-31 | $0.11B | $0.79B | 14.38% |
| 2015-09-30 | $0.10B | $0.75B | 13.67% |
| 2015-06-30 | $0.10B | $0.72B | 13.99% |
| 2015-03-31 | $0.10B | $0.68B | 14.31% |
| 2014-12-31 | $0.09B | $0.64B | 14.49% |
| 2014-09-30 | $0.09B | $0.61B | 14.16% |
| 2014-06-30 | $0.08B | $0.58B | 14.38% |
| 2014-03-31 | $0.07B | $0.55B | 12.61% |
| 2013-12-31 | $0.07B | $0.52B | 13.18% |
| 2013-09-30 | $0.07B | $0.49B | 13.99% |
| 2013-06-30 | $0.06B | $0.46B | 13.95% |
| 2013-03-31 | $0.08B | $0.43B | 17.84% |
| 2012-12-31 | $0.07B | $0.40B | 18.68% |
| 2012-09-30 | $0.07B | $0.37B | 18.27% |
| 2012-06-30 | $0.07B | $0.26B | 25.88% |
| 2012-03-31 | $0.06B | $0.17B | 36.26% |
| 2011-12-31 | $0.06B | $0.08B | 68.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.230B | $2.939B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.365B | 21.69 |
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| IDEXX Laboratories (IDXX) | United States | $44.716B | 43.08 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| STERIS (STE) | Ireland | $21.830B | 22.08 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.199B | 9.72 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Elekta AB (EKTAY) | Sweden | $2.226B | 20.13 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| Tandem Diabetes Care (TNDM) | United States | $1.314B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.772B | 4.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Accuray (ARAY) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |